Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Board/Management Information 2015

Nov 18, 2015

6785_rns_2015-11-18_7c43034a-54ae-4620-bf95-7b15f26d916e.htm

Board/Management Information

Open in viewer

Opens in your device viewer

_________ false

C002����� ��"�2PublicEVOGENE LTD10571Corporation no: 512838723Stock Exchange/Market: -12369380Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: [email protected] via MAGNA: 18/11/2015              Time of broadcast: 14:08 14:07:05

Company site: www.evogene.com

Reference: 2015-02-157869

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Changes in Management
Evogene_Changes_in_Management_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 04/11/2015
- - -
Name of the Signatory: : Masliah Sassi , Position of Signatory in the reporting corporation: Adv., Corporate Secretary , Name of Employer Company: .
Eizenberg Aharon Telephone: 08-9311971 , Facsimile: 08-9466724 , E-mail: [email protected] 1